{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:33:31Z","timestamp":1786793611259,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11033-021-06152-z","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T10:03:13Z","timestamp":1612173793000},"page":"1801-1817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types"],"prefix":"10.1007","volume":"48","author":[{"given":"Saber","family":"Soltani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Zakeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tabibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Zakeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Siavoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Seifpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-2612","authenticated-orcid":false,"given":"Abbas","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"11","key":"6152_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.bbamcr.2010.06.013","volume":"1803","author":"F Wahid","year":"2010","unstructured":"Wahid F, Shehzad A, Khan T, Kim YY (2010) MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta (BBA): Mol Cell Res 1803(11):1231\u20131243","journal-title":"Biochim Biophys Acta (BBA): Mol Cell Res"},{"issue":"2","key":"6152_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233","journal-title":"Cell"},{"issue":"20","key":"6152_CR3","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20):4051\u20134060","journal-title":"EMBO J"},{"key":"6152_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fimmu.2019.00695","volume":"10","author":"A Hassani","year":"2019","unstructured":"Hassani A, Khan G (2019) Epstein-Barr virus and miRNAs: partners in crime in the pathogenesis of multiple sclerosis? Front Immunol 10:695","journal-title":"Front Immunol"},{"issue":"1","key":"6152_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","volume":"410","author":"J Lu","year":"2011","unstructured":"Lu J, Murakami M, Verma SC, Cai Q, Haldar S, Kaul R et al (2011) Epstein\u2013Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410(1):64\u201375","journal-title":"Virology"},{"issue":"5","key":"6152_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u2013854","journal-title":"Cell"},{"issue":"5","key":"6152_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/ijbs.24562","volume":"14","author":"M Wang","year":"2018","unstructured":"Wang M, Yu F, Wu W, Wang Y, Ding H, Qian L (2018) Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. Int J Biol Sci 14(5):565","journal-title":"Int J Biol Sci"},{"issue":"18","key":"6152_CR8","doi-asserted-by":"publisher","first-page":"10029","DOI":"10.1128\/JVI.02241-06","volume":"81","author":"P Zou","year":"2007","unstructured":"Zou P, Kawada J, Pesnicak L, Cohen JI (2007) Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. J Virol 81(18):10029\u201310036","journal-title":"J Virol"},{"issue":"1","key":"6152_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-9378-9-34","volume":"9","author":"G Pannone","year":"2014","unstructured":"Pannone G, Zamparese R, Pace M, Pedicillo MC, Cagiano S, Somma P et al (2014) The role of EBV in the pathogenesis of Burkitt\u2019s lymphoma: an Italian hospital based survey. Infect Agents Cancer 9(1):34","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"6152_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.beha.2012.01.005","volume":"25","author":"M Roschewski","year":"2012","unstructured":"Roschewski M, Wilson WH (2012) EBV-associated lymphomas in adults. Best Pract Res Clin Haematol 25(1):75\u201389","journal-title":"Best Pract Res Clin Haematol"},{"issue":"33","key":"6152_CR11","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young LS, Murray PG (2003) Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22(33):5108\u20135121","journal-title":"Oncogene"},{"key":"6152_CR12","first-page":"2655","volume":"2","author":"A Rickinson","year":"2007","unstructured":"Rickinson A, Kieff E (2007) Epstein-Barr virus. Fields Virol 2:2655\u20132700","journal-title":"Fields Virol"},{"key":"6152_CR13","first-page":"2603","volume":"2","author":"A Rickinson","year":"2006","unstructured":"Rickinson A (2006) Epstein-Barr virus and its replication. Virology 2:2603\u20132654","journal-title":"Virology"},{"issue":"5","key":"6152_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","volume":"13","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A, Dotti G (2008) EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 13(5):577","journal-title":"Oncologist"},{"key":"6152_CR15","volume-title":"Fields virology","author":"E Kieff","year":"1996","unstructured":"Kieff E (1996) Epstein-Barr virus and its replication. In: Fields virology. Lippincott Williams & Wilkins, Philadelphia"},{"issue":"3","key":"6152_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3816\/CLM.2009.n.042","volume":"9","author":"H Mani","year":"2009","unstructured":"Mani H, Jaffe ES (2009) Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma 9(3):206\u2013216","journal-title":"Clin Lymphoma Myeloma"},{"issue":"11","key":"6152_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1593\/neo.09888","volume":"11","author":"RW-M Lung","year":"2009","unstructured":"Lung RW-M, Tong JH-M, Sung Y-M, Leung P-S, Ng DC-H, Chau S-L et al (2009) Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11(11):1174\u2013IN17","journal-title":"Neoplasia"},{"issue":"7","key":"6152_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein\u2013Barr virus infection. N Engl J Med 343(7):481\u2013492","journal-title":"N Engl J Med"},{"issue":"5740","key":"6152_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"CL Jopling","year":"2005","unstructured":"Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740):1577\u20131581","journal-title":"Science"},{"issue":"5818","key":"6152_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1126\/science.1136319","volume":"315","author":"R Triboulet","year":"2007","unstructured":"Triboulet R, Mari B, Lin Y-L, Chable-Bessia C, Bennasser Y, Lebrigand K et al (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315(5818):1579\u20131582","journal-title":"Science"},{"issue":"1","key":"6152_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-9378-9-12","volume":"9","author":"MR Ambrosio","year":"2014","unstructured":"Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S et al (2014) The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agents Cancer 9(1):12","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"6152_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.18632\/oncotarget.4399","volume":"7","author":"PP Piccaluga","year":"2016","unstructured":"Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F et al (2016) Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget 7(1):224","journal-title":"Oncotarget"},{"key":"6152_CR23","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.12659\/MSM.897306","volume":"22","author":"L Zhou","year":"2016","unstructured":"Zhou L, Bu Y, Liang Y, Zhang F, Zhang H, Li S (2016) Epstein-Barr Virus (EBV)-BamHI-A rightward transcript (BART)-6 and cellular microRNA-142 synergistically compromise immune defense of host cells in EBV-positive burkitt lymphoma. Med Sci Monitor: Int Med J Exp Clin Res 22:4114","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"issue":"4","key":"6152_CR24","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3892\/mmr.2017.6173","volume":"15","author":"YM Zhang","year":"2017","unstructured":"Zhang YM, Yu Y, Zhao HP (2017) EBV-BART-6-3p and cellular microRNA-197 compromise the immune defense of host cells in EBV-positive Burkitt lymphoma. Mol Med Rep 15(4):1877\u20131883","journal-title":"Mol Med Rep"},{"key":"6152_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fmicb.2017.00501","volume":"8","author":"CI Oduor","year":"2017","unstructured":"Oduor CI, Movassagh M, Kaymaz Y, Chelimo K, Otieno J, Ong'echa JM et al (2017) Human and Epstein-barr virus miRNA profiling as predictive biomarkers for endemic Burkitt lymphoma. Front Microbiol 8:501","journal-title":"Front Microbiol"},{"key":"6152_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fmicb.2015.00556","volume":"6","author":"M Navari","year":"2015","unstructured":"Navari M, Etebari M, De Falco G, Ambrosio MR, Gibellini D, Leoncini L et al (2015) The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. Front Microbiol 6:556","journal-title":"Front Microbiol"},{"issue":"22","key":"6152_CR27","doi-asserted-by":"publisher","first-page":"11670","DOI":"10.1128\/JVI.01248-10","volume":"84","author":"SD Linnstaedt","year":"2010","unstructured":"Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84(22):11670\u201311678","journal-title":"J Virol"},{"issue":"1","key":"6152_CR28","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"RL Skalsky","year":"2012","unstructured":"Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M et al (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8(1):e1002484","journal-title":"PLoS Pathog"},{"issue":"11","key":"6152_CR29","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/ajt.13503","volume":"15","author":"A Harris-Arnold","year":"2015","unstructured":"Harris-Arnold A, Arnold C, Schaffert S, Hatton O, Krams S, Esquivel C et al (2015) Epstein\u2013Barr virus modulates host cell nicroRNA-194 to promote IL-10 production and B lymphoma cell survival. Am J Transplant 15(11):2814\u20132824","journal-title":"Am J Transplant"},{"issue":"8","key":"6152_CR30","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3109\/10428194.2012.659736","volume":"53","author":"JH Kim","year":"2012","unstructured":"Kim JH, Kim WS, Park C (2012) Epstein\u2013Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1. Leukemia Lymphoma 53(8):1586\u20131591","journal-title":"Leukemia Lymphoma"},{"issue":"3","key":"6152_CR31","doi-asserted-by":"publisher","first-page":"e01297","DOI":"10.1128\/JVI.01297-18","volume":"93","author":"H Ayoubian","year":"2019","unstructured":"Ayoubian H, Ludwig N, Fehlmann T, Menegatti J, Gr\u00f6ger L, Anastasiadou E et al (2019) Epstein-Barr virus infection of cell lines derived from diffuse large B-cell lymphomas alters microRNA loading of the Ago2 complex. J Virol 93(3):e01297\u2013e01318","journal-title":"J Virol"},{"issue":"23","key":"6152_CR32","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.18632\/oncotarget.2952","volume":"5","author":"TA de Andrade","year":"2014","unstructured":"de Andrade TA, Evangelista AF, Campos AHF, Poles WA, Borges NM, Camillo CMC et al (2014) A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly. Oncotarget 5(23):11813","journal-title":"Oncotarget"},{"issue":"5","key":"6152_CR33","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","volume":"39","author":"J Imig","year":"2010","unstructured":"Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T et al (2010) microRNA profiling in Epstein\u2013Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39(5):1880\u20131893","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6152_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1186\/s12885-018-5205-9","volume":"18","author":"P Cao","year":"2018","unstructured":"Cao P, Zhang M, Wang L, Sai B, Tang J, Luo Z et al (2018) miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas. BMC Cancer 18(1):1293","journal-title":"BMC Cancer"},{"issue":"8","key":"6152_CR35","doi-asserted-by":"publisher","first-page":"e42193","DOI":"10.1371\/journal.pone.0042193","volume":"7","author":"N Motsch","year":"2012","unstructured":"Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T et al (2012) MicroRNA profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing. PLoS One 7(8):e42193","journal-title":"PLoS One"},{"issue":"5","key":"6152_CR36","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ajpath.2015.01.025","volume":"185","author":"H-H Chen","year":"2015","unstructured":"Chen H-H, Huang W-T, Yang L-W, Lin C-W (2015) The PTEN-AKT-mTOR\/RICTOR pathway in nasal natural killer cell lymphoma is activated by miR-494-3p via PTEN but inhibited by miR-142-3p via RICTOR. Am J Pathol 185(5):1487\u20131499","journal-title":"Am J Pathol"},{"issue":"2","key":"6152_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/gcc.20273","volume":"45","author":"J Kluiver","year":"2006","unstructured":"Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ et al (2006) Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45(2):147\u2013153","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"6152_CR38","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","volume":"111","author":"A Navarro","year":"2008","unstructured":"Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balagu\u00e9 O et al (2008) MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111(5):2825\u20132832","journal-title":"Blood"},{"issue":"4","key":"6152_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/hon.2360","volume":"35","author":"Y Komabayashi","year":"2017","unstructured":"Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y (2017) Circulating Epstein-Barr virus\u2013encoded micro-RNAs as potential biomarkers for nasal natural killer\/T-cell lymphoma. Hematol Oncol 35(4):655\u2013663","journal-title":"Hematol Oncol"},{"issue":"11","key":"6152_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027271","volume":"6","author":"R Ramakrishnan","year":"2011","unstructured":"Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP et al (2011) Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One 6(11):e27271","journal-title":"PLoS One"},{"issue":"5","key":"6152_CR41","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.ajpath.2013.01.025","volume":"182","author":"T-C Lin","year":"2013","unstructured":"Lin T-C, Liu T-Y, Hsu S-M, Lin C-W (2013) Epstein-Barr virus\u2013encoded miR-BART20-5p Inhibits T-bet translation with secondary suppression of p53 in invasive Nasal NK\/T-cell lymphoma. Am J Pathol 182(5):1865\u20131875","journal-title":"Am J Pathol"},{"issue":"1","key":"6152_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/leu.2011.189","volume":"26","author":"D Martin-Perez","year":"2012","unstructured":"Martin-Perez D, Vargiu P, Montes-Moreno S, Leon E, Rodriguez-Pinilla S, Lisio L et al (2012) Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia 26(1):180","journal-title":"Leukemia"},{"issue":"5","key":"6152_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","volume":"68","author":"T Xia","year":"2008","unstructured":"Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB et al (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68(5):1436\u20131442","journal-title":"Cancer Res"},{"issue":"8","key":"6152_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002193","volume":"7","author":"J Qiu","year":"2011","unstructured":"Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J et al (2011) A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7(8):e1002193","journal-title":"PLoS Pathog"},{"issue":"11","key":"6152_CR45","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/ajt.12858","volume":"14","author":"S Fink","year":"2014","unstructured":"Fink S, Gandhi M, Nourse J, Keane C, Jones K, Crooks P et al (2014) A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors. Am J Transplant 14(11):2577\u20132587","journal-title":"Am J Transplant"},{"issue":"4","key":"6152_CR46","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","volume":"184","author":"W-T Huang","year":"2014","unstructured":"Huang W-T, Lin C-W (2014) EBV-Encoded miR-BART20-5p and miR-BART8 Inhibit the IFN-\u03b3\u2013STAT1 pathway associated with disease progression in Nasal NK-cell lymphoma. Am J Pathol 184(4):1185\u20131197","journal-title":"Am J Pathol"},{"issue":"2","key":"6152_CR47","first-page":"98","volume":"70","author":"KL L\u00f3pez-Facio","year":"2013","unstructured":"L\u00f3pez-Facio KL, Egu\u00eda-Aguilar P, Valencia-Mayoral P, P\u00e9rezpe\u00f1a-D\u00edazconti M, Arenas-Huertero F (2013) Expression of BART-5, BART-16 and BART-22, and NF-\u03baB factor in classic Hodgkin\u2019s lymphoma in pediatric patients. Bol Med Hosp Infant Mex 70(2):98\u2013106","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"9822","key":"6152_CR48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G et al (2012) Burkitt's lymphoma. Lancet 379(9822):1234\u20131244","journal-title":"Lancet"},{"key":"6152_CR49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"issue":"4","key":"6152_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ijc.2910290406","volume":"29","author":"A Geser","year":"1982","unstructured":"Geser A, De Th\u00e9 G, Lenoir G, Day N, Williams E (1982) Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphoma. Int J Cancer 29(4):397\u2013400","journal-title":"Int J Cancer"},{"key":"6152_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-3-642-67236-1_14","volume-title":"The Epstein-Barr Virus","author":"M Epstein","year":"1979","unstructured":"Epstein M, Achong B (1979) The relationship of the virus to Burkitt\u2019s lymphoma. In: The Epstein-Barr Virus. Springer, Berlin, pp 321\u2013337"},{"issue":"5","key":"6152_CR52","first-page":"285","volume":"3","author":"I Magrath","year":"1992","unstructured":"Magrath I, Jain V, Bhatia K (1992) Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 3(5):285\u2013295","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"6152_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/1471-2164-10-407","volume":"10","author":"Y Chen","year":"2009","unstructured":"Chen Y, Gelfond JA, McManus LM, Shireman PK (2009) Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10(1):407","journal-title":"BMC Genomics"},{"issue":"8","key":"6152_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/14728222.2012.696102","volume":"16","author":"WC Cho","year":"2012","unstructured":"Cho WC (2012) MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets 16(8):747\u2013759","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"6152_CR55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.trsl.2011.01.013","volume":"157","author":"SP Nana-Sinkam","year":"2011","unstructured":"Nana-Sinkam SP, Croce CM (2011) MicroRNAs as therapeutic targets in cancer. Transl Res 157(4):216\u2013225","journal-title":"Transl Res"},{"issue":"3","key":"6152_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1517\/14728222.2011.550878","volume":"15","author":"P Gandellini","year":"2011","unstructured":"Gandellini P, Profumo V, Folini M, Zaffaroni N (2011) MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets 15(3):265\u2013279","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"6152_CR57","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1158\/1078-0432.CCR-13-3157","volume":"20","author":"CY Ok","year":"2014","unstructured":"Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC et al (2014) Prevalence and clinical implications of Epstein\u2013Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res 20(9):2338\u20132349","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6152_CR58","first-page":"972","volume":"110","author":"S Park","year":"2007","unstructured":"Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC et al (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. J Am Soc Hematol 110(3):972\u2013978","journal-title":"J Am Soc Hematol"},{"issue":"s3","key":"6152_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ajt.12004","volume":"13","author":"M Green","year":"2013","unstructured":"Green M, Michaels M (2013) Epstein\u2013Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 13(s3):41\u201354","journal-title":"Am J Transplant"},{"issue":"9","key":"6152_CR60","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","volume":"158","author":"PR Beatty","year":"1997","unstructured":"Beatty PR, Krams SM, Martinez OM (1997) Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 158(9):4045\u20134051","journal-title":"J Immunol"},{"issue":"50","key":"6152_CR61","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","volume":"24","author":"JR Testa","year":"2005","unstructured":"Testa JR, Tsichlis PN (2005) AKT signaling in normal and malignant cells. Oncogene 24(50):7391\u20137393","journal-title":"Oncogene"},{"issue":"24","key":"6152_CR62","doi-asserted-by":"publisher","first-page":"21843","DOI":"10.1074\/jbc.M109745200","volume":"277","author":"Y Ogawara","year":"2002","unstructured":"Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K et al (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277(24):21843\u201321850","journal-title":"J Biol Chem"},{"key":"6152_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.gmit.2015.08.003","volume":"5","author":"W Abe","year":"2016","unstructured":"Abe W, Nasu K, Tsuno A, Kawano Y, Narahara H (2016) Gynecol Minimally Invas Ther 5:106\u2013108","journal-title":"Gynecol Minimally Invas Ther"},{"key":"6152_CR64","doi-asserted-by":"crossref","unstructured":"Young H, Bream J. (2007) IFN-\u03b3: recent advances in understanding regulation of expression, biological functions, and clinical applications. Interferon: The 50th Anniversary: Springer, pp. 97\u2013117","DOI":"10.1007\/978-3-540-71329-6_6"},{"issue":"4","key":"6152_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nri2276","volume":"8","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8(4):259\u2013268","journal-title":"Nat Rev Immunol"},{"key":"6152_CR66","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES (2001) World Health Organization classification of tumours. In: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06152-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T21:17:11Z","timestamp":1674940631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06152-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["6152"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06152-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"All data generated or analyzed during this study are included in this published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}